The potential impact of azithromycin in idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

The potential impact of azithromycin in idiopathic pulmonary fibrosis

Published:2019-02 Issue:2 Volume:53 Page:1800628
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Macaluso Claudio,Maritano Furcada Joaquín,Alzaher Omamah,Chaube Ritesh,Chua Felix,Wells Athol U.,Maher Toby M.,George Peter M.,Renzoni Elizabeth A.,Molyneaux Philip L.

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference11 articles.

1. The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis

2. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study;Han;Lancet Respir Med,2014

3. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis;Molyneaux;Respir Res,2017

4. Host–Microbial Interactions in Idiopathic Pulmonary Fibrosis

5. Patterns and economic burden of hospitalizations and exacerbations among patients diagnosed with idiopathic pulmonary fibrosis;Yu;J Manag Care Spec Pharm,2016

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silica aggravates pulmonary fibrosis through disrupting lung microbiota and amino acid metabolites;Science of The Total Environment;2024-10

2. Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype;Frontiers in Immunology;2024-08-15

3. Application of Microbiome-Based Therapies in Chronic Respiratory Diseases;Journal of Microbiology;2024-03

4. Macrolides and Interstitial Lung Diseases;Progress in Inflammation Research;2024

5. Commensal Oral Microbiota, Disease Severity and Mortality in Fibrotic Lung Disease;American Journal of Respiratory and Critical Care Medicine;2023-12-05